Accedi

Bibliografie tematiche / Drug Resistance / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Drug Resistance.

Articoli di riviste sul tema "Drug Resistance"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 25 luglio 2025

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Drug Resistance".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

K, Tiwari. "Drug Resistance: Challenges and Updates." Journal of Natural & Ayurvedic Medicine 3, no. 3 (2019): 1–2. http://dx.doi.org/10.23880/jonam-16000196.

Testo completo

Abstract (sommario):

Use of antibiotics increased dramatically in last two decades. To cure most of the diseases broad spectrum antibiotics given. Human society and healthcare is going in wrong direction. One way the pharmaceutical companies are making huge money from it. The other way around is the overuse of these antibiotics, by patients knowing or unknowingly, not only making pathogens adapted but also the normal flora organisms becoming pathogens in coming future? Present article highlight the issues and possible solution of the present scenario.

Gli stili APA, Harvard, Vancouver, ISO e altri

2

T.V., Sowjanya* B. Akhila N. Ahalya T. Sai Ram T. Maneesha V. Pavithra. "Drug Resistance In Various Disorders." International Journal in Pharmaceutical Sciences 2, no. 2 (2024): 558–64. https://doi.org/10.5281/zenodo.10684813.

Testo completo

Abstract (sommario):

Drug resistance is the ability of microorganisms, such as bacteria, viruses, or parasites, to withstand the effects of drugs that were intended to kill or inhibit their growth. In developed countries, drug resistance is the primary cause of death, the burden of infectious diseases is comparatively greater, and patients with a resistance are less likely to be able to afford secondary line treatments, which typically have more complex regimens than first line drugs. Nowadays, antibiotic resistance is increasing. Some of the common drug resistances like Bacteria, Cancer, Diabetes, Leprosy, and HI

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Singh, Amresh Kumar. "Resistance patterns and trends of extensively drug-resistant tuberculosis: 5-year experience." Journal of Microbiology and Infectious Diseases 03, no. 04 (2013): 169–75. http://dx.doi.org/10.5799/ahinjs.02.2013.04.0103.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Dyary, Hiewa Othman. "Veterinary Anthelmintics and Anthelmintic Drug Resistance." Journal of Zankoy Sulaimani - Part A 18, no. 1 (2015): 191–206. http://dx.doi.org/10.17656/jzs.10463.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Çelik, Cem. "Increasing antimicrobial resistance in nosocomial pathogens; multidrug-resistant extensively drug-resistant and pandrug-resistant Acinetobacter baumannii." Journal of Microbiology and Infectious Diseases 4, no. 1 (2014): 7–12. http://dx.doi.org/10.5799/ahinjs.02.2014.01.0116.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Xiaoping, Zhang, and Yu Xiangmin. "Research Progress on Drug-Resistant Bacteria." International Journal of Sciences Volume 8, no. 2019-06 (2019): 1–5. https://doi.org/10.5281/zenodo.3350755.

Testo completo

Abstract (sommario):

More and more microorganisms have developed drug resistance with the use of antibiotics, and some microorganisms have multi-drug resistance. Therefore, bacterial resistant antibiotic is a serious problem to treating infectious diseases in recent years all over the world. This paper briefly reviews the research progress of bacterial resistance mechanisms all over the world, and provides theoretical basis for exploring effective prevention measures and rational use antibiotics in clinical.Read Complete Article at ijSciences: V82019052079 AND DOI: http://dx.doi.org/10.18483/ijSci.2079

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Giaccone, Giuseppe, and Herbert M. Pinedo. "Drug Resistance." Oncologist 1, no. 1-2 (1996): 82–87. http://dx.doi.org/10.1634/theoncologist.1-1-82.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Hochhauser, D., and A. L. Harris. "Drug resistance." British Medical Bulletin 47, no. 1 (1991): 178–96. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072454.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Prichard, R. K. "Drug resistance." International Journal for Parasitology 29, no. 1 (1999): 137–38. http://dx.doi.org/10.1016/s0020-7519(98)00191-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Texidó, Gemma, and Jürgen Moll. "Drug resistance." Drug Discovery Today: Technologies 11 (March 2014): 1–3. http://dx.doi.org/10.1016/j.ddtec.2014.03.013.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Köser, Claudio U., Babak Javid, Kathleen Liddell, et al. "Drug-resistance mechanisms and tuberculosis drugs." Lancet 385, no. 9965 (2015): 305–7. http://dx.doi.org/10.1016/s0140-6736(14)62450-8.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Coen, Donald M., and Richard J. Whitley. "Antiviral drugs and antiviral drug resistance." Current Opinion in Virology 1, no. 6 (2011): 545–47. http://dx.doi.org/10.1016/j.coviro.2011.10.024.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Hall, Andrew G., and Julie Irving. "New drugs, new drug resistance mechanisms." Expert Review of Anticancer Therapy 2, no. 3 (2002): 239–340. http://dx.doi.org/10.1586/14737140.2.3.239.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Kumar, Saurabh, and Richa Prasad Mahato. "DRUG RESISTANCE AND RESISTANCE REVERSAL STRATEGIES IN MALARIA PARASITE." Journal of microbiology, biotechnology and food sciences 13, no. 5 (2024): e10384. http://dx.doi.org/10.55251/jmbfs.10384.

Testo completo

Abstract (sommario):

The public health care system is currently facing a major problem with malaria. Globally, malarial deaths have decreased by an estimated 40% in the past two decades because of the clinically effective drugs (artemisinin-based combination therapies) against Plasmodium falciparum. In recent years, P falciparum develop resistance against all antimalarial drugs and then becomes developed multidrug resistance that a major challenge. Even though drug discovery programs have made substantial progress in the past decade, the potential for new drugs/combinations to improve the effectiveness of current

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Yusuf, Yenni. "ANTI-MALARIAL DRUG RESISTANCE." Majalah Kedokteran Andalas 37, no. 1 (2015): 64. http://dx.doi.org/10.22338/mka.v37.i1.p64-69.2014.

Testo completo

Abstract (sommario):

AbstrakTujuan studi ini adalah untuk menjelaskan mekanisme resistensi parasit malaria danusaha-usaha yang dapat dilakukan untuk menghadapi munculnya strain parasit yangresisten terhadap artemisinin. Metode yang digunakan adalah studi kepustakaan. ResistensiP.falciparum terhadap obat-obat anti malaria disebabkan oleh perubahan spontan yangterjadi pada beberapa gen seperti P.falciparum multi drug resistance1 (Pfmdr1), P.falciparumchloroquine transporter (Pfcrt), P.falciparum dihydropteroate synthase (Pfdhps), P.falciparumdihydrofolate reductase (Pfdhfr), and P.falciparum multidrug resistance-ass

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Kennedy, David A., and Andrew F. Read. "Why does drug resistance readily evolve but vaccine resistance does not?" Proceedings of the Royal Society B: Biological Sciences 284, no. 1851 (2017): 20162562. http://dx.doi.org/10.1098/rspb.2016.2562.

Testo completo

Abstract (sommario):

Why is drug resistance common and vaccine resistance rare? Drugs and vaccines both impose substantial pressure on pathogen populations to evolve resistance and indeed, drug resistance typically emerges soon after the introduction of a drug. But vaccine resistance has only rarely emerged. Using well-established principles of population genetics and evolutionary ecology, we argue that two key differences between vaccines and drugs explain why vaccines have so far proved more robust against evolution than drugs. First, vaccines tend to work prophylactically while drugs tend to work therapeuticall

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Nyce, J., S. Leonard, D. Canupp, S. Schulz, and S. Wong. "Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance." Proceedings of the National Academy of Sciences 90, no. 7 (1993): 2960–64. http://dx.doi.org/10.1073/pnas.90.7.2960.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

Hossain, Chowdhury Mobaswar, Lisa Kathleen Ryan, Meeta Gera, et al. "Antifungals and Drug Resistance." Encyclopedia 2, no. 4 (2022): 1722–37. http://dx.doi.org/10.3390/encyclopedia2040118.

Testo completo

Abstract (sommario):

Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal). Antibiotics also prevent bacterial infections through either bacteriostatic or bactericidal mechanisms. These microorganisms successfully develop resistance against conventional drugs that are designed to kill or stop them from multiplying. When a fungus no longer responds to antifungal drug treatments and continues to grow, this is known as antifungal drug resistance. Bacteria have an amazing capacity to become res

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Perfect, John R., and Gary M. Cox. "Drug resistance in Cryptococcus neoformans." Drug Resistance Updates 2, no. 4 (1999): 259–69. http://dx.doi.org/10.1054/drup.1999.0090.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Croft, Simon L., Shyam Sundar, and Alan H. Fairlamb. "Drug Resistance in Leishmaniasis." Clinical Microbiology Reviews 19, no. 1 (2006): 111–26. http://dx.doi.org/10.1128/cmr.19.1.111-126.2006.

Testo completo

Abstract (sommario):

SUMMARY Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is caused by over 15 different species of the protozoan parasite genus Leishmania. There are significant differences in the sensitivity of these species both to the standard drugs, for example, pentavalent antimonials and miltefosine, and those on clinical trial, for example, paromomycin. Over 60% of patients with visceral leishmaniasis in Bihar State, India, do not respond to treatment with pentavalent antimonials. This is now considered to be due to acquired resistance. Although this class of drugs ha

Gli stili APA, Harvard, Vancouver, ISO e altri

21

de Koning, Harry P. "Drug resistance in protozoan parasites." Emerging Topics in Life Sciences 1, no. 6 (2017): 627–32. http://dx.doi.org/10.1042/etls20170113.

Testo completo

Abstract (sommario):

As with all other anti-infectives (antibiotics, anti-viral drugs, and anthelminthics), the limited arsenal of anti-protozoal drugs is being depleted by a combination of two factors: increasing drug resistance and the failure to replace old and often shamefully inadequate drugs, including those compromised by (cross)-resistance, through the development of new anti-parasitics. Both factors are equally to blame: a leaking bathtub may have plenty of water if the tap is left open; if not, it will soon be empty. Here, I will reflect on the factors that contribute to the drug resistance emergency tha

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Rabab, Batool, Imran Muhammad, Hafeez Kandhro Abdul, Salahuddin Naseem, and K. H. Uddin Muhammad. "Resistance Patterns among Multidrug-Resistant Tuberculosis Patients: A Multi-Center Study from Pakistan." International Journal of Endorsing Health Science Research 5, no. 4 (2017): 07–11. https://doi.org/10.29052/IJEHSR.v5.i4.2017.07-11.

Testo completo

Abstract (sommario):

Abstract <strong>Background:</strong> The high burden of multi-drug resistance tuberculosis (MDR TB) is a matter of great concern.  The increasing resistance to anti tuberculosis drugs has been the area of growing concern and are posing threats to TB control. The aim of this study was to evaluate the drug resistance patterns for the first line and second line anti-Tuberculosis drugs in multiple drug resistant tuberculosis (MDR-TB) patients. <strong>Method:</strong> The study was retrospective, observational, employing purposive, non-random sampling technique for data collection

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Wtorek, Karol, Angelika Długosz, and Anna Janecka. "Drug resistance in topoisomerase-targeting therapy." Postępy Higieny i Medycyny Doświadczalnej 72 (December 21, 2018): 1073–83. http://dx.doi.org/10.5604/01.3001.0012.8131.

Testo completo

Abstract (sommario):

Drug resistance is a well-known phenomenon that occurs when initially responsive to chemotherapy cancer cells become tolerant and elude further effectiveness of anticancer drugs. Based on their mechanism of action, anticancer drugs can be divided into cytotoxic-based agents and target-based agents. An important role among the therapeutics of the second group is played by drugs targeting topoisomerases, nuclear enzymes critical to DNA function and cell survival. These enzymes are cellular targets of several groups of anticancer agents which generate DNA damage in rapidly proliferating cancer ce

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Freire, Tomas Ferreira Amaro, Zhijian Hu, Kevin B. Wood, and Erida Gjini. "Modeling spatial evolution of multi-drug resistance under drug environmental gradients." PLOS Computational Biology 20, no. 5 (2024): e1012098. http://dx.doi.org/10.1371/journal.pcbi.1012098.

Testo completo

Abstract (sommario):

Multi-drug combinations to treat bacterial populations are at the forefront of approaches for infection control and prevention of antibiotic resistance. Although the evolution of antibiotic resistance has been theoretically studied with mathematical population dynamics models, extensions to spatial dynamics remain rare in the literature, including in particular spatial evolution of multi-drug resistance. In this study, we propose a reaction-diffusion system that describes the multi-drug evolution of bacteria based on a drug-concentration rescaling approach. We show how the resistance to drugs

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Kurt Yilmaz, Nese, and Celia A. Schiffer. "Introduction: Drug Resistance." Chemical Reviews 121, no. 6 (2021): 3235–37. http://dx.doi.org/10.1021/acs.chemrev.1c00118.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Emery, VC. "Cytomegalovirus Drug Resistance." Antiviral Therapy 3, no. 4 (1998): 239–42. http://dx.doi.org/10.1177/135965359800300403.

Testo completo

Abstract (sommario):

Clinical resistance of cytomegalovirus (CMV) against the currently licensed antiviral drugs is becoming an increasingly recognized problem. This review focuses on the molecular basis of resistance and describes mutations in the UL54 DNA polymerase leading to resistance against cidofovir, foscarnet and ganciclovir. The review highlights two important developments in our appreciation of resistance. Firstly, the use of more rapid molecular based assays to detect genotypic resistance and secondly, the relationship between resistance profiles in multiple organ systems of the same host. Finally, the

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Clavel, François, and Allan J. Hance. "HIV Drug Resistance." New England Journal of Medicine 350, no. 10 (2004): 1023–35. http://dx.doi.org/10.1056/nejmra025195.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Richman, D. D. "HIV Drug Resistance." Annual Review of Pharmacology and Toxicology 33, no. 1 (1993): 149–64. http://dx.doi.org/10.1146/annurev.pa.33.040193.001053.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Davies, Peter, and Damian Cullen. "Antituberculosis drug resistance." Clinical Medicine 9, no. 1 (2009): 91.1–91. http://dx.doi.org/10.7861/clinmedicine.9-1-91.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Perrin, Luc. "Drug resistance mutations." AIDS 18, no. 8 (2004): 1201–2. http://dx.doi.org/10.1097/00002030-200405210-00014.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

White, Nicholas J. "Antimalarial drug resistance." Journal of Clinical Investigation 113, no. 8 (2004): 1084–92. http://dx.doi.org/10.1172/jci21682.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Tesio, Melania. "Starving Drug Resistance." HemaSphere 4, no. 6 (2020): e495. http://dx.doi.org/10.1097/hs9.0000000000000495.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Pizzorno, Andrés, Yacine Abed, and Guy Boivin. "Influenza Drug Resistance." Seminars in Respiratory and Critical Care Medicine 32, no. 04 (2011): 409–22. http://dx.doi.org/10.1055/s-0031-1283281.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

COEN, DONALD M. "Antiviral Drug Resistance." Annals of the New York Academy of Sciences 616, no. 1 AIDS (1990): 224–36. http://dx.doi.org/10.1111/j.1749-6632.1990.tb17843.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Weitzman, Jonathan B. "Cancer drug resistance." Genome Biology 2 (2001): spotlight—20010626–01. http://dx.doi.org/10.1186/gb-spotlight-20010626-01.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Smirnov, G. B. "Bacterial drug-resistance." Molecular Genetics, Microbiology and Virology (Russian) 42, no. 3 (2024): 43. http://dx.doi.org/10.17116/molgen20244203143.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Flintoff, Wayne F. "Acquired drug resistance." Genome 31, no. 1 (1989): 447. http://dx.doi.org/10.1139/g89-073.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Gold, Howard S., and Robert C. Moellering. "Antimicrobial-Drug Resistance." New England Journal of Medicine 335, no. 19 (1996): 1445–53. http://dx.doi.org/10.1056/nejm199611073351907.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Phelps, Charles E. "Bug/Drug Resistance." Medical Care 27, no. 2 (1989): 194–203. http://dx.doi.org/10.1097/00005650-198902000-00009.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Robertson, John D. "CANCER DRUG RESISTANCE." Shock 26, no. 6 (2006): 638. http://dx.doi.org/10.1097/01.shk.0000248599.09507.90.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

RICHMAN, DOUGLAS D. "HIV Drug Resistance." AIDS Research and Human Retroviruses 8, no. 6 (1992): 1065–71. http://dx.doi.org/10.1089/aid.1992.8.1065.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Schmit, Jean-Claude. "HIV drug resistance." HIV Clinical Trials 3, no. 3 (2002): 225–26. http://dx.doi.org/10.1310/kmkn-ke48-2gwu-g0he.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Richman, Douglas D. "Viral drug resistance." Current Opinion in Infectious Diseases 3, no. 6 (1990): 819–23. http://dx.doi.org/10.1097/00001432-199012000-00014.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Loeffler, Juergen, and David A. Stevens. "Antifungal Drug Resistance." Clinical Infectious Diseases 36, Supplement_1 (2003): S31—S41. http://dx.doi.org/10.1086/344658.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Richman, Douglas D. "Antiviral drug resistance." Antiviral Research 71, no. 2-3 (2006): 117–21. http://dx.doi.org/10.1016/j.antiviral.2006.03.004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Calmy, Alexandra, Fernando Pascual, and Nathan Ford. "HIV Drug Resistance." New England Journal of Medicine 350, no. 26 (2004): 2720–21. http://dx.doi.org/10.1056/nejm200406243502621.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Pillay, D., and A. M. Geddes. "Antiviral drug resistance." BMJ 313, no. 7056 (1996): 503–4. http://dx.doi.org/10.1136/bmj.313.7056.503.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Richman, Douglas D. "Antiretroviral drug resistance." AIDS 5, Supplement (1991): 189. http://dx.doi.org/10.1097/00002030-199101001-00027.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Richman, Douglas D. "HIV DRUG RESISTANCE." AIDS 8, Supplement 4 (1994): S3. http://dx.doi.org/10.1097/00002030-199411004-00010.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

STEVENSON, AUDREY M. "Emerging Drug Resistance." MCN, The American Journal of Maternal/Child Nursing 23, no. 4 (1998): 216. http://dx.doi.org/10.1097/00005721-199807000-00010.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!